TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants January 10, 1975
TCL Archive In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work June 20, 1986
TCL Archive In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years October 7, 1977
TCL Archive NCI Searching for Scientists With “Fire in Belly” As Associate Director for Biological Carcinogenesis June 19, 1987
